75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study

BACKGROUND: The primary analysis of the STAT study demonstrated the feasibility, efficacy, and safety of using DTG/3TC as a first-line regimen in a test-and-treat setting through 24 weeks, with therapy adjustments for baseline resistance or hepatitis B virus (HBV) co-infection. Here we present secon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolle, Charlotte-Paige M, Berhe, Mezgebe, Singh, Tulika, Ortiz, Roberto, Wurapa, Anson K, Ramgopal, Moti, Jayaweera, Dushyantha, Leone, Peter, Matthews, Jessica, Cupo, Michael, Underwood, Mark, Angelis, Kostas, Wynne, Brian, Merrill, Deanna, Nguyen, Christopher T, van Wyk, Jean A, Zolopa, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644878/
http://dx.doi.org/10.1093/ofid/ofab466.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644878/
http://dx.doi.org/10.1093/ofid/ofab466.075

Ejemplares similares